title: [Treatment of alcoholic liver diseases and psychiatric and psychosocial problems].
abstract: Only about 15% of the subjects abusing ethanol will eventually develop cirrhosis of the liver, suggesting that other factors in addition to the consumption of large quantities of ethanol play a role in the pathogenesis of alcoholic cirrhosis. Important contributors may be infection with hepatitis viruses, in particular HCV, protein-calorie malnutrition and immunologic factors. Abstinence improves the prognosis of patients with alcoholic cirrhosis, provided that the liver disease is not too far advanced. No pharmacotherapeutic intervention has shown a convincing improvement of the prognosis of alcoholic liver disease, so that the therapeutic efforts should be mainly directed towards abstinence. The patient with alcoholic liver disease needs support and guidance by the treating physicians. Supportive treatment with Disulfiram, Acamprosate or Naltrexon can help with achieving durable abstinence.
authors.affiliation: Psychiatrische Poliklinik, Universität Bern.
authors.forename: H U
authors.initials: HU
authors.lastname: Fisch
authors.forename: B H
authors.initials: BH
authors.lastname: Lauterburg
mesh_terms: D000427:Alcohol Deterrents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000523:psychology / Q000534:rehabilitation*; D010348:Patient Care Team; D011604:Psychoses, Alcoholic / Q000523:psychology / Q000534:rehabilitation*; D012940:Social Problems / Q000523:psychology*; D013695:Temperance / Q000523:psychology
chemical_list: D000427:Alcohol Deterrents